γ-AApeptides-based Small Molecule Ligands That Disaggregate Human Islet Amyloid Polypeptide

Area of Science:

• Biochemistry
• Molecular Biology
• Medical Research

Background:

• Protein misfolding and amyloid aggregation are hallmarks of age-related diseases like Type II diabetes.
• Human islet amyloid polypeptide (hIAPP) aggregation is a key factor in Type II diabetes pathogenesis.
• Preventing protein aggregate formation is crucial for disease progression.

Purpose of the Study:

• To investigate the amyloid-prevention capabilities of HW-155 analogues against hIAPP fibrillization.
• To evaluate the potential of peptidomimetics derived from combinatorial libraries as therapeutic agents.

Main Methods:

• Screening of a one-bead-one compound (OBOC) library to identify HW-155.
• Synthesis and characterization of eight HW-155 analogues.
• Evaluation of the inhibitory effects on hIAPP fibril formation.

Main Results:

• HW-155 and all eight analogues demonstrated effectiveness in inhibiting hIAPP fibril formation.
• The analogues showed significant amyloid-prevention capabilities.
• The study confirms the potential of HW-155 derivatives in combating hIAPP aggregation.

Conclusions:

• HW-155 analogues are potent inhibitors of hIAPP aggregation.
• These findings suggest a promising therapeutic avenue for Type II diabetes and other amyloid-related diseases.
• Further research into these peptidomimetics could lead to novel treatments.